GANGAPHARMACEUTICALSLTD logo

Ganga Pharmaceuticals Ltd

GANGAPHARMACEUTICALSLTD·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap7.40 Cr
PE Ratio73.50
Volume—
Day High - Low—
52W High-Low13.97 - 9.35

Ganga Pharmaceuticals Ltd (GANGAPHARMACEUTICALSLTD): company summary

Ganga Pharmaceuticals Ltd (GANGAPHARMACEUTICALSLTD) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.

Ganga Pharmaceuticals Ltd (GANGAPHARMACEUTICALSLTD) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing steadily at 7.9% a year over three years; profit grew 35.7% a year, ahead of revenue — margins are expanding. Return on equity is 1.3%.
Valuation multiples
The stock trades at 73.5 times earnings, a premium to the Healthcare median of 32.0, 0.89 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
1.30%
Weak
P/E
73.50x
Expensive
Debt / Equity
0.13
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

52W₹9.35
₹13.97
DocStoX take

Supported by growth (6.0), but held back by quality (2.1). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
4.0
/10
Weak
Quality
Weak
ROE 1.3%
Valuation
Expensive
P/E 73.5×
Growth
Steady
Revenue +6.4% 5Y CAGR
Risk
Moderate
D/E 0.13
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹7 Cr
52W High / Low
₹14 / ₹9
Dividend Yield
0.00%
Promoter Holding
50.91%
EPS (TTM)
₹0.17
Book Value
₹14.06

Key highlights

  • Profit compounding 38% a year
  • Low leverage — D/E 0.13
  • Profitable in all of the last 5 years
  • Quality is weak (2.1/10)
  • Valuation is weak (2.4/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Ganga Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.